铁筷子多糖联合内分泌治疗晚期前列腺癌的疗效  

Clinical Study of Helleborusthibetanus Franch Polysaccharide(HFPS)Combined with Endocrine Therapy for Advanced Prostate Cancer

作　　者：程璐[1] 曾昭昌 刘远灵[1] 郑秋平 万颂 华伟[1] 周宇林 江文聪 杨盛帮[2] 习明[1] CHENG Lu;ZENG Zhao-chang;LIU Yuan-ling(Huadu District People's of Guangzhou,Guangzhou Guangdong 510800)

机构地区：[1]广州市花都区人民医院,广东广州510800 [2]广州市第一人民医院,广东广州510180

出　　处：《医学临床研究》2022年第7期995-998,共4页Journal of Clinical Research

基　　金：广州市中医药和中西医结合科技项目(20192A010029)。

摘　　要：【目的】探讨铁筷子多糖联合内分泌治疗晚期前列腺癌的临床疗效及铁筷子多糖对前列腺癌细胞的抑制作用。【方法】回顾性分析两院收治的154例晚期前列腺癌患者的临床资料,根据治疗方法的不同将其分为对照组(内分泌治疗)和观察组(铁筷子多糖联合内分泌治疗),每组77例。比较两组患者治疗前后前列腺特异抗原(PSA)和游离前列腺特异抗原(F-PSA)水平,比较两组患者生活质量及国际前列腺癌症状量表(I-PSS)评分,比较不同剂量铁筷子多糖对DU145细胞周期的影响。【结果】治疗后,两组患者PSA、F-PSA水平低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组患者QLQ-C30评分、I-PSS评分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。高剂量组G0/G1期细胞比例显著低于对照组、低剂量组,差异有统计学意义(P<0.05);高剂量组、低剂量组S期细胞比例显著高于对照组,低剂量组高于对照组(P<0.05)。观察组的并发症发生率低于对照组,差异有统计学意义(P<0.05)。【结论】铁筷子多糖联合内分泌治疗晚期前列腺癌临床疗效较好,且铁筷子多糖可较好抑制前列腺癌细胞。【Objective】To investigate the clinical efficacy of Helleborusthibetanus Franch polysaccharide(HFPS)combined with endocrine therapy for advanced prostate cancer and its inhibitory effect on prostate cancer cells.【Methods】The clinical data of 154 patients with advanced prostate cancer treated in our hospital were retrospectively analyzed.According to the different treatment methods,they were divided into control group(endocrine therapy)and observation group(Helleborusthibetanus Franch combined with endocrine therapy),with 77 cases in each group.The levels of prostate-specific antigen(PSA)and free prostate-specific antigen(F-PSA)were compared between the two groups before and after treatment.The quality of life and international prostate cancer symptom scale(I-PSS)scores of the two groups were compared,and the effects of different doses of HFPS on DU145 cell cycle were compared.【Results】After treatment,the levels of PSA and F-PSA in the two groups were lower than those before treatment,and those in the observation group were lower than those in the control group,the difference was statistically significant(P<0.05);The QLQ-C30 and I-PSS scores of the two groups were lower than those before treatment,and the observation group was lower than that of the control group,the difference was statistically significant(P<0.05).The proportion of G0/G1 cells in the high-dose group was significantly lower than that in the control group and low-dose group(P<0.05);The proportion of S-phase cells in the high-dose group and the low-dose group was significantly higher than that in the control group,and that in the low-dose group was higher than that in the control group(P<0.05).The incidence of complications in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).【Conclusion】Helleborusthibetanus Franch polysaccharide(HFPS)combined with endocrine therapy has a good clinical effect on advanced prostate cancer,and Helleborusthibetanus Franch polysaccharide

关 键 词：前列腺肿瘤/中西医结合疗法 前列腺肿瘤/病理学 铁筷子属/药物作用 雄激素拮抗药/治疗应用 

分 类 号：R737.25[医药卫生—肿瘤]